EUVIMEDEUVIMED entdecken
Crossref

Development of an Antiviral Medicinal Plant and Natural Product Database (avMpNp Database) from Biodiversity

Daniela Quadros de Azevedo iD, João Vinícius Viera Nóia iD, Yasmim Carla M Ribeiro iD, Raphael Alves Dos Reis iD, Paulo Henrique Otoni Ribeiro iD, Gustavo Almeida Moura iD, Pamela Mendes iD, Ana Beatriz Barbosa de Souza iD, Sofia Carpini Mermejo iD, Mateus Sá Magalhães Serafim iD, Thaís Helena Maciel Fernandes iD, Anthony J O'Donoghue iD und 4 weitere

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202400285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Daniela Quadros de Azevedo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG. 31270-901, Brazil. Hauptthemen laut MEDLINE: Antiviral Agents, Plants, Medicinal, Biological Products, SARS-CoV-2. Die Arbeit nennt 76 Literaturangaben. Gefördert von: CAPES, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, CNPq.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The construction of compound databases (DB) is a strategy for the rational search of bioactive compounds and drugs for new and old diseases. In order to bring greater impact to drug discovery, we propose the development of a DB of bioactive antiviral compounds. Several research groups have presented evidence of the antiviral activity of medicinal plants and compounds isolated from these plants. We believe that compiling these discoveries in a DB would benefit the scientific research community and increase the speed to discover new potential drugs and medicines. Thus, we present the Antiviral Medicinal Plant and Natural Product DB (avMpNp DB) as an important source for acquiring, organizing, and distributing knowledge related to natural products and antiviral drug discovery. The avMpNp DB contains a series of chemically diverse compounds with drug‐like profiles. To test the potential of this DB, SARS‐CoV‐2 M pro and PL pro enzymatic inhibition assays were performed for available compounds resulting in IC 50 values ranging from 6.308±0.296 to 15.795±0.155 μM. As a perspective, artificial intelligence tools will be added to implement computational predictions, as well as other chemical functionalities that allow data validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsPlants, MedicinalBiological ProductsSARS-CoV-2HumansCoronavirus 3C ProteasesDatabases, FactualDrug DiscoveryCOVID-19 Drug Treatment

Stichwörter der Autor:innen

DatabaseNatural productsSARS-CoV-2Virus

Substanzen

Antiviral AgentsBiological ProductsCoronavirus 3C Proteases3C-like proteinase, SARS-CoV-2

Autor:innen und Institutionen

  • Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG. 31270-901, Brazil.
  • Departamento de Ciência da Computação, Instituto de Ciências Exatas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
  • Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
  • Departamento de Matéria Prima, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Rio Grande do Sul, RS, Brazil.
  • Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego (UCSD), San Diego, CA, US.

ORCID-Profile: Daniela Quadros de Azevedo, João Vinícius Viera Nóia, Yasmim Carla M Ribeiro, Raphael Alves Dos Reis, Paulo Henrique Otoni Ribeiro, Gustavo Almeida Moura, Pamela Mendes, Ana Beatriz Barbosa de Souza, Sofia Carpini Mermejo, Mateus Sá Magalhães Serafim, Thaís Helena Maciel Fernandes, Anthony J O'Donoghue, Alessandra C Faria Aguiar Campos, Sérgio Vale Aguiar Campos, Vinícius Gonçalves Maltarollo, Rachel Oliveira Castilho

Förderung

  • CAPES
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • CNPq
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • FAPEMIG
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • UFMG
  • Universidade Federal de Minas Gerais

Zitieren

APA

Quadros de Azevedo, D., Vinícius Viera Nóia, J., Ribeiro, Y. C. M., Alves Dos Reis, R., Ribeiro, P. H. O., Almeida Moura, G., Mendes, P., Barbosa de Souza, A. B., Carpini Mermejo, S., Serafim, M. S. M., Fernandes, T. H. M., O'Donoghue, A. J., Campos, A. C. F. A., Campos, S. V. A., Gonçalves Maltarollo, V., & Oliveira Castilho, R. (2024). Development of an Antiviral Medicinal Plant and Natural Product Database (avMpNp Database) from Biodiversity. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202400285

Vancouver

Quadros de Azevedo D, Vinícius Viera Nóia J, Ribeiro YCM, Alves Dos Reis R, Ribeiro PHO, Almeida Moura G, et al. Development of an Antiviral Medicinal Plant and Natural Product Database (avMpNp Database) from Biodiversity. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202400285

BibTeX
@article{QuadrosdeAzevedo2024,
  author = {Quadros de Azevedo, Daniela and Vinícius Viera Nóia, João and Ribeiro, Yasmim Carla M and Alves Dos Reis, Raphael and Ribeiro, Paulo Henrique Otoni and Almeida Moura, Gustavo and Mendes, Pamela and Barbosa de Souza, Ana Beatriz and Carpini Mermejo, Sofia and Serafim, Mateus Sá Magalhães and Fernandes, Thaís Helena Maciel and O'Donoghue, Anthony J and Campos, Alessandra C Faria Aguiar and Campos, Sérgio Vale Aguiar and Gonçalves Maltarollo, Vinícius and Oliveira Castilho, Rachel},
  title = {Development of an Antiviral Medicinal Plant and Natural Product Database (avMpNp Database) from Biodiversity},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202400285}
}
Kostenlos starten →